BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9268048)

  • 21. Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides.
    Pérez HL; Lähdetie J; Landin H; Kilpeläinen I; Koivisto P; Peltonen K; Osterman-Golkar S
    Chem Biol Interact; 1997 Aug; 105(3):181-98. PubMed ID: 9291996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of DNA damage by alkaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene.
    Vangala RR; Laib RJ; Bolt HM
    Arch Toxicol; 1993; 67(1):34-8. PubMed ID: 8452477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
    Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
    Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
    Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
    Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
    Motwani HV; Törnqvist M
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.
    Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Ménache MG
    Res Rep Health Eff Inst; 2000 Mar; (92):11-43; discussion 45-8. PubMed ID: 10925838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
    Melnick RL; Huff J
    Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micronuclei and gene mutations in transgenic big Blue((R)) mouse and rat fibroblasts after exposure to the epoxide metabolites of 1, 3-butadiene.
    Erexson GL; Tindall KR
    Mutat Res; 2000 Dec; 472(1-2):105-17. PubMed ID: 11113703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic effects of 1,3-butadiene on the mouse testis.
    Brinkworth MH; Anderson D; Hughes JA; Jackson LI; Yu TW; Nieschlag E
    Mutat Res; 1998 Jan; 397(1):67-75. PubMed ID: 9463553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.
    Johanson G; Filser JG
    Arch Toxicol; 1993; 67(3):151-63. PubMed ID: 8494494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
    Bond JA; Medinsky MA
    Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
    Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
    Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene.
    Leavens TL; Farris GM; James RA; Shah R; Wong VA; Marshall MW; Bond JA
    Environ Mol Mutagen; 1997; 29(4):335-45. PubMed ID: 9212784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
    Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
    Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats.
    Cunningham MJ; Choy WN; Arce GT; Rickard LB; Vlachos DA; Kinney LA; Sarrif AM
    Mutagenesis; 1986 Nov; 1(6):449-52. PubMed ID: 3331684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micronuclei are induced in rat spermatids in vitro by 1,2,3,4-diepoxybutane but not by 1,2-epoxy-3-butene and 1,2-dihydroxy-3,4-epoxybutane.
    Sjöblom T; Lähdetie J
    Mutagenesis; 1996 Sep; 11(5):525-8. PubMed ID: 8921516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
    Boogaard PJ; de Kloe KP; Booth ED; Watson WP
    Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micronucleus induction in germ and somatic cells of the mouse after exposure to the butadiene metabolites diepoxybutane and epoxybutene.
    Russo A; Nogara C; Renzi L; Tommasi AM
    Mutat Res; 1997 Apr; 390(1-2):129-39. PubMed ID: 9150761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis.
    Kreiling R; Laib RJ; Filser JG; Bolt HM
    Arch Toxicol; 1987; 61(1):7-11. PubMed ID: 3439877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.